#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Cold type haemolytic anaemia Malignant neoplasm of choroid Pituitary-dependent Cushing's syndrome Leiomyosarcoma Behcet's syndrome Sjogren's syndrome Acute graft versus host disease in skin Follicle centre lymphoma follicular grade I, II – III Interstitial lung disease Thromboangiitis obliterans Myelin oligodendrocyte glycoprotein antibody-associated disease Myeloid leukaemia Neuroblastoma recurrent Hodgkin's disease recurrent Laryngeal squamous cell carcinoma More trials…
Learn about Rare Diseases

Medulloblastoma recurrent – Treatment Adrenogenital syndrome – Basic Information Progressive multifocal leukoencephalopathy – Life with Disease Acquired haemophilia – Basic Information Haemophilia B with anti factor IX – Diagnostics Kearns-Sayre syndrome – Life with Disease Short-bowel syndrome – Basic Information Systemic mastocytosis – Life with Disease Idiopathic pulmonary fibrosis – Basic Information IgA nephropathy – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Golodirsen Atropine Sulfate Monohydrate Diclofenac Diethylamine Darovasertib Tranexamic Acid RIVASTIGMINE Ferric Carboxymaltose Dostarlimab Migalastat Dextran 70 Fenebrutinib Alx148 Ceftazidime Clomipramine Hydrochloride Rasagiline Omp72 Ag-946 Phosphate Oxygen Albaconazole Cevostamab More therapies…

Learn about Your Condition

Gastrooesophageal cancer Vascular calcification Invasive breast carcinoma Neuroblastoma recurrent Mixed dementia Renal cancer recurrent Myelodysplastic syndrome Amyotrophic lateral sclerosis Cleft lip and palate Post procedural swelling Laryngeal cancer stage III Double hit lymphoma Circulatory collapse Neonatal respiratory failure End stage renal disease More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Plasma cell leukaemia

Study on the Safety and Effectiveness of ARI0002h and Drug Combination for Newly Diagnosed Primary Plasma Cell Leukemia Patients

Recruiting

2 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of Bortezomib and Daratumumab for Patients with Primary Plasma Cell Leukemia

Recruiting

2 1 1 1
Investigated Drugs:
Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell leukaemia
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Plasma cell leukaemia

Study on the Safety and Effectiveness of ARI0002h and Drug Combination for Newly Diagnosed Primary Plasma Cell Leukemia Patients

Study on the Effectiveness and Safety of Bortezomib and Daratumumab for Patients with Primary Plasma Cell Leukemia

Study on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies